Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Provider and Public Health Input for Vaccine Policy Decisions, Potential Extramural Project (PEP), 2007-R-04

---
identifier: "/us/fr/E7-6010"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Provider and Public Health Input for Vaccine Policy Decisions, Potential Extramural Project (PEP), 2007-R-04"
title_number: 0
title_name: "Federal Register"
section_number: "E7-6010"
section_name: "Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Provider and Public Health Input for Vaccine Policy Decisions, Potential Extramural Project (PEP), 2007-R-04"
positive_law: false
currency: "2007-04-02"
last_updated: "2007-04-02"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E7-6010"
document_type: "notice"
publication_date: "2007-04-02"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "72 FR 15697"
fr_volume: 72
---


#  Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Provider and Public Health Input for Vaccine Policy Decisions, Potential Extramural Project (PEP), 2007-R-04

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting.

*Time and Date:* 12 p.m.-4 p.m., May 8, 2007 (Closed).

*Place:* Teleconference.

*Status:* The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to PEP 2007-R-04, “Provider and Public Health Input for Vaccine Policy Decisions.”

*Contact Person for More Information:* Christine J. Morrison, PhD Scientific Review Administrator, Office of the Chief Science Officer, CDC, 1600 Clifton Road NE, Mailstop D-72, Atlanta, GA 30333, Telephone (404)639-3098.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: March 26, 2007.

Elaine L. Baker,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.